Guardado en:
Detalles Bibliográficos
Autores principales: Slootweg, Ivan, García-De-La-Puente, Natalia P., Litjens, Geert, Dammak, Salma
Formato: Preprint
Publicado: 2025
Materias:
Acceso en línea:https://arxiv.org/abs/2509.00131
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866912559795273728
author Slootweg, Ivan
García-De-La-Puente, Natalia P.
Litjens, Geert
Dammak, Salma
author_facet Slootweg, Ivan
García-De-La-Puente, Natalia P.
Litjens, Geert
Dammak, Salma
contents Kidney abnormality detection is required for all preclinical drug development. It involves a time-consuming and costly examination of hundreds to thousands of whole-slide images per drug safety study, most of which are normal, to detect any subtle changes indicating toxic effects. In this study, we present the first large-scale self-supervised abnormality detection model for kidney toxicologic pathology, spanning drug safety assessment studies from 158 compounds. We explore the complexity of kidney abnormality detection on this scale using features extracted from the UNI foundation model (FM) and show that a simple k-nearest neighbor classifier on these features performs at chance, demonstrating that the FM-generated features alone are insufficient for detecting abnormalities. We then demonstrate that a self-supervised method applied to the same features can achieve better-than-chance performance, with an area under the receiver operating characteristic curve of 0.62 and a negative predictive value of 89%. With further development, such a model can be used to rule out normal slides in drug safety assessment studies, reducing the costs and time associated with drug development.
format Preprint
id arxiv_https___arxiv_org_abs_2509_00131
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Self-supervised large-scale kidney abnormality detection in drug safety assessment studies
Slootweg, Ivan
García-De-La-Puente, Natalia P.
Litjens, Geert
Dammak, Salma
Computer Vision and Pattern Recognition
Image and Video Processing
Quantitative Methods
Kidney abnormality detection is required for all preclinical drug development. It involves a time-consuming and costly examination of hundreds to thousands of whole-slide images per drug safety study, most of which are normal, to detect any subtle changes indicating toxic effects. In this study, we present the first large-scale self-supervised abnormality detection model for kidney toxicologic pathology, spanning drug safety assessment studies from 158 compounds. We explore the complexity of kidney abnormality detection on this scale using features extracted from the UNI foundation model (FM) and show that a simple k-nearest neighbor classifier on these features performs at chance, demonstrating that the FM-generated features alone are insufficient for detecting abnormalities. We then demonstrate that a self-supervised method applied to the same features can achieve better-than-chance performance, with an area under the receiver operating characteristic curve of 0.62 and a negative predictive value of 89%. With further development, such a model can be used to rule out normal slides in drug safety assessment studies, reducing the costs and time associated with drug development.
title Self-supervised large-scale kidney abnormality detection in drug safety assessment studies
topic Computer Vision and Pattern Recognition
Image and Video Processing
Quantitative Methods
url https://arxiv.org/abs/2509.00131